- Home
- ALLY vs RVTY Comparison
ALLY vs RVTY Comparison
Compare ALLY & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALLY | RVTY |
|---|---|---|
| Founded | 1919 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 11.8B |
| IPO Year | 2011 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ALLY | RVTY |
|---|---|---|
| Price | $42.75 | $93.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 16 |
| Target Price | $52.00 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 3.0M | 797.9K |
| Earning Date | 04-17-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.82% | 0.30% |
| EPS Growth | ★ 31.67 | N/A |
| EPS | ★ 2.37 | 2.07 |
| Revenue | ★ $7,914,000,000.00 | $3,311,822,000.00 |
| Revenue This Year | $24.36 | $6.34 |
| Revenue Next Year | $6.21 | $5.14 |
| P/E Ratio | ★ $17.98 | $45.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.91 | $81.36 |
| 52 Week High | $47.27 | $118.30 |
Technical Indicators
Market Signals| Indicator | ALLY | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 66.44 | 59.23 |
| Support Level | $37.64 | $88.73 |
| Resistance Level | $43.66 | $95.14 |
| Average True Range (ATR) | 0.97 | 2.96 |
| MACD | 0.46 | 1.17 |
| Stochastic Oscillator | 96.59 | 89.69 |
Price Performance
Historical ComparisonAbout ALLY Ally Financial Inc.
Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending, with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.